Ablation devices Global Market - Forecast to 2023

Publishing Date : March, 2017
Report Code : HCMD 0112
Price:
Single license $4,950
Site license $6,750
Global license $9,000


Ablation is the minimally invasive therapeutic tissue excision procedure used for a wide range of purposes, from cancerous or diseased tissue removal, to the removal of abnormally conducting cardiac tissue in atrial fibrillation and others. The growing adoption of minimally invasive procedures is pushing the researchers to innovate and improvise existing ablation technologies for better patient care.

The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023. The ablation device global market by technology is segmented into thermal ablation and non thermal ablation. The thermal ablation technologies are radiation therapy, cryoablation, radiofrequency, laser, ultrasound, microwave, and hydrothermal ablation technology. Among thermal ablation, radiofrequency ablation accounted for the largest share in 2016 and microwave is expected to grow at highest CAGR from 2016-2023. Non thermal technology includes electroporation, mechanical ablation and others (Chemical). Among non thermal ablation technologies, electroporation generated the largest share in 2016, and is expected to grow at a mid single digit CAGR from 2016-2023.   

By application, the ablation device global market is segmented oncology, cardiovascular diseases, ophthalmology, cosmetology, gynaecology, general surgery, urology, orthopaedics, pain management and others. Atrial Fibrilation, Ventricular Tachycardia and Others are the segments in cardiovascular application. Oncology is holding the largest revenue in 2016 and cardiovascular application is expected to grow at a high CAGR from 2016-2023.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and speciality clinics. Hospitals generated the largest revenue in 2016 and are expected to grow at high CAGR from 2016-2023
By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the ablation device market.

The ablation device market is expected to grow at high single digit CAGR from 2016-2023. The major factor influencing the growth are increasing number of ablation procedures, rising incidence of cancer, emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets are some of the factors driving the market.  However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market.

The ablation device global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the ablation device global market include Boston Scientific Corporation (U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic (Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan), ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.), Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
• North America
• Europe
• Asia-Pacific
• Rest of the World (RoW)

TABLE OF CONTENTS

  • 1     EXECUTIVE SUMMARY
  • 2     INTRODUCTION
    • 2.1     KEY TAKE AWAYS
    • 2.2     REPORT DESCRIPTION
    • 2.3     MARKETS COVERED
    • 2.4     STAKEHOLDERS
    • 2.5     RESEARCH METHODOLOGY
      • 2.5.1     MARKET SIZE ESTIMATION
      • 2.5.2     MARKET BREAKDOWN & DATA TRIANGULATION
      • 2.5.3     SECONDARY SOURCES
      • 2.5.4     KEY DATA POINTS FROM SECONDARY SOURCES
      • 2.5.5     PRIMARY SOURCES
      • 2.5.6     KEY DATA POINTS FROM PRIMARY SOURCES
      • 2.5.7     ASSUMPTIONS
  • 3     MARKET ANALYSIS
    • 3.1     INTRODUCTION
    • 3.2     MARKET SEGMENTATION
    • 3.3     FACTORS INFLUENCING MARKET
      • 3.3.1     DRIVERS AND OPPORTUNITIES
        • 3.3.1.1     INCREASING AGING POPULATION
        • 3.3.1.2     RISING INCIDENCE OF CANCER AND CARDIOVASCULAR DISEASES
        • 3.3.1.3     GROWING ADOPTION OF MINIMALLY INVASIVE PROCEDURES
        • 3.3.1.4     IMPROVING REIMBURSEMENT SCENARIO IN ESTABLISHED MARKETS
        • 3.3.1.5     EMERGENCE OF NEXT-GENERATION ABLATION PRODUCTS AND TECHNOLOGIES
        • 3.3.1.6     INCREASING NUMBER OF ABLATION PROCEDURES
        • 3.3.1.7     INCREASING FUNDING FOR THE DEVELOPMENT OF NOVEL ABLATION DEVICE
        • 3.3.1.8     EMERGING APAC MARKETS
      • 3.3.2     RESTRAINTS & THREATS
        • 3.3.2.1     REUSE AND REPROCESSING OF DEVICES IN DEVELOPING COUNTRIES
        • 3.3.2.2     HEALTHCARE COST CONTAINMENT MEASURES
        • 3.3.2.3     STRINGENT REGULATORY APPROVALS
        • 3.3.2.4     CHALLENGES IN THERAPEUTIC PROCEDURES
    • 3.4     UPCOMING TECHNOLOGY
    • 3.5     REIMBURSEMENT
    • 3.6     REGULATORY AFFAIRS
      • 3.6.1     U.S.
      • 3.6.2     EUROPE
      • 3.6.3     INDIA
      • 3.6.4     CHINA
      • 3.6.5     JAPAN
    • 3.7     PATENT TRENDS
    • 3.8     SUPPLY CHAIN ANALYSIS
    • 3.9     PORTER’S FIVE FORCE ANALYSIS
      • 3.9.1     THREAT OF NEW ENTRANTS
      • 3.9.2     THREAT OF SUBSTITUTES
      • 3.9.3     BARGAINING POWER OF SUPPLIERS
      • 3.9.4     BARGAINING POWER OF BUYERS
      • 3.9.5     RIVALRY AMONG EXISTING COMPETITORS
    • 3.10     MARKET SHARE ANALYSIS
      • 3.10.1     MARKET SHARE ANALYSIS BY ABLATION DEVICE MAJOR PLAYERS
      • 3.10.2     MARKET SHARE ANALYSIS BY ATRIAL FIBRILLATION ABLATION DEVICE MAJOR PLAYERS
      • 3.10.3     MARKET SHARE ANALYSIS BY RADIATION ABLATION DEVICE MAJOR PLAYERS
  • 4     ABLATION DEVICE GLOBAL MARKET, BY TECHNOLOGY
    • 4.1     INTRODUCTION
    • 4.2     THERMAL ABLATION
      • 4.2.1     RADIOFREQUENCY ABLATION
      • 4.2.2     LASER ABLATION TECHNOLOGY
      • 4.2.3     MICROWAVE ABLATION TECHNOLOGY
      • 4.2.4     ULTRASOUND ABLATION TECHNOLOGY
      • 4.2.5     RADIATION ABLATION TECHNOLOGY
      • 4.2.6     CRYOABLATION TECHNOLOGY
      • 4.2.7     HYDROTHERMAL ABLATION TECHNOLOGY
    • 4.3     NON-THERMAL TECHNOLOGY BASED ABLATION
      • 4.3.1     ELECTROPORATION ABLATION TECHNOLOGY
      • 4.3.2     MECHANICAL ABLATION TECHNOLOGY
      • 4.3.3     OTHERS
  • 5     ABLATION DEVICE GLOBAL MARKET, BY APPLICATION
    • 5.1     INTRODUCTION
    • 5.2     ONCOLOGY
    • 5.3     CARDIOVASCULAR
      • 5.3.1     ATRIAL FIBRILATION (AF/AFIB)
      • 5.3.2     VENTRICULAR TACHYCARDIA (VT)
      • 5.3.3     OTHERS
    • 5.4     OPHTHALMOLOGY
    • 5.5     COSMETOLOGY
    • 5.6     GYNECOLOGY
    • 5.7     GENERAL SURGERY
    • 5.8     UROLOGY
    • 5.9     ORTHOPEDICS
    • 5.10     PAIN MANAGEMENT
    • 5.11     OTHER
  • 6     ABLATION DEVICE GLOBAL MARKET, BY END-USERS
    • 6.1     INTRODUCTION
    • 6.2     HOSPITALS
    • 6.3     AMBULATORY SURGICAL CENTRES
    • 6.4     SPECIALITY CLINICS
  • 7     REGIONAL MARKET ANALYSIS
    • 7.1     INTRODUCTION
    • 7.2     NORTH AMERICA
      • 7.2.1     U.S.
      • 7.2.2     OTHERS
    • 7.3     EUROPE
      • 7.3.1     U.K.
      • 7.3.2     GERMANY
      • 7.3.3     FRANCE
      • 7.3.4     OTHERS
    • 7.4     ASIA PACIFIC
      • 7.4.1     INDIA
      • 7.4.2     CHINA
      • 7.4.3     JAPAN
      • 7.4.4     OTHERS
    • 7.5     REST OF THE WORLD
      • 7.5.1     MIDDLE EAST
      • 7.5.2     BRAZIL
      • 7.5.3     OTHERS
  • 8     COMPANY DEVELOPMENTS
    • 8.1     INTRODUCTION
      • 8.1.1     MERGER AND ACQUISITION AS A MAJOR GROWTH STRATEGY OF ABLATION DEVICE MARKET PLAYERS
    • 8.2     MERGERS AND ACQUISITIONS
    • 8.3     APPROVAL
    • 8.4     NEW PRODUCT LAUNCH
    • 8.5     AGREEMENTS PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
    • 8.6     BUSINESS EXPANSION
  • 9     MAJOR PLAYER PROFILES
    • 9.1     ABBOTT LABORATORIES (ST JUDE MEDICAL)
      • 9.1.1     OVERVIEW
      • 9.1.2     FINANCIALS
      • 9.1.3     PRODUCT PORTFOLIO
      • 9.1.4     KEY DEVELOPMENTS
      • 9.1.5     BUSINESS STRATEGY
      • 9.1.6     SWOT ANALYSIS
    • 9.2     ANGIODYNAMICS INC.
      • 9.2.1     OVERVIEW
      • 9.2.2     FINANCIALS
      • 9.2.3     PRODUCT PORTFOLIO
      • 9.2.4     KEY DEVELOPMENTS
      • 9.2.5     BUSINESS STRATEGY
      • 9.2.6     SWOT ANALYSIS
    • 9.3     ARTICURE INC.
      • 9.3.1     OVERVIEW
      • 9.3.2     FINANCIALS
      • 9.3.3     PRODUCT PORTFOLIO
      • 9.3.4     KEY DEVELOPMENTS
      • 9.3.5     BUSINESS STRATEGY
      • 9.3.6     SWOT ANALYSIS
    • 9.4     BOSTON SCIENTIFIC CORPORATION
      • 9.4.1     OVERVIEW
      • 9.4.2     FINANCIALS
      • 9.4.3     PRODUCT PORTFOLIO
      • 9.4.4     KEY DEVELOPMENTS
      • 9.4.5     BUSINESS STRATEGY
      • 9.4.6     SWOT ANALYSIS
    • 9.5     CONMED CORPORATION
      • 9.5.1     OVERVIEW
      • 9.5.2     FINANCIALS
      • 9.5.3     PRODUCT PORTFOLIO
      • 9.5.4     KEY DEVELOPMENTS
      • 9.5.5     BUSINESS STRATEGY
      • 9.5.6     SWOT ANALYSIS
    • 9.6     ELEKTA AB
      • 9.6.1     OVERVIEW
      • 9.6.2     FINANCIALS
      • 9.6.3     PRODUCT PORTFOLIO
      • 9.6.4     KEY DEVELOPMENTS
      • 9.6.5     BUSINESS STRATEGY
      • 9.6.6     SWOT ANALYSIS
    • 9.7     HOLOGIC INC.
      • 9.7.1     OVERVIEW
      • 9.7.2     FINANCIALS
      • 9.7.3     PRODUCT PORTFOLIO
      • 9.7.4     KEY DEVELOPMENTS
      • 9.7.5     BUSINESS STRATEGY
      • 9.7.6     SWOT ANALYSIS
    • 9.8     JOHNSON & JOHNSON
      • 9.8.1     OVERVIEW
      • 9.8.2     FINANCIALS
      • 9.8.3     PRODUCT PORTFOLIO
      • 9.8.4     KEY DEVELOPMENTS
      • 9.8.5     BUSINESS STRATEGY
      • 9.8.6     SWOT ANALYSIS
    • 9.9     MEDTRONIC, PLC
      • 9.9.1     OVERVIEW
      • 9.9.2     FINANCIALS
      • 9.9.3     PRODUCT PORTFOLIO
      • 9.9.4     KEY DEVELOPMENTS
      • 9.9.5     BUSINESS STRATEGY
      • 9.9.6     SWOT ANALYSIS
    • 9.10     OLYMPUS CORPORATION
      • 9.10.1     OVERVIEW
      • 9.10.2     FINANCIALS
      • 9.10.3     PRODUCT PORTFOLIO
      • 9.10.4     KEY DEVELOPMENTS
      • 9.10.5     BUSINESS STRATEGY
      • 9.10.6     SWOT ANALYSIS
    • 9.11     SMITH & NEPHEW PLC
      • 9.11.1     OVERVIEW
      • 9.11.2     FINANCIALS
      • 9.11.3     PRODUCT PORTFOLIO
      • 9.11.4     KEY DEVELOPMENTS
      • 9.11.5     BUSINESS STRATEGY
      • 9.11.6     SWOT ANALYSIS
    • 9.12     STRYKER CORPORATION
      • 9.12.1     OVERVIEW
      • 9.12.2     FINANCIALS
      • 9.12.3     PRODUCT PORTFOLIO
      • 9.12.4     KEY DEVELOPMENTS
      • 9.12.5     BUSINESS STRATEGY
      • 9.12.6     SWOT ANALYSIS
    • 9.13     VARIAN MEDICAL SYSTEMS
      • 9.13.1     OVERVIEW
      • 9.13.2     FINANCIALS
      • 9.13.3     PRODUCT PORTFOLIO
      • 9.13.4     KEY DEVELOPMENTS
      • 9.13.5     BUSINESS STRATEGY
      • 9.13.6     SWOT ANALYSIS

      LIST OF TABLES

      • TABLE 1     ABLATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 2     ABLATION DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 3     ABLATION DEVICES GLOBAL MARKET, BY APPLICATION (2015-2023) ($MN)
      • TABLE 4     ABLATION DEVICES GLOBAL MARKET REVENUE, BY END-USER,(2015-2023) ($MN)
      • TABLE 5     ABLATION DEVICE TECHNIQUES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 6     ABLATION DEVICE GLOBAL MARKET REVENUE, BY TECHNOLOGY,(2015-2023) ($MN)
      • TABLE 7     THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 8     THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
      • TABLE 9     RADIOFREQUENCY TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 10     LASER TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN)
      • TABLE 11     MICROWAVE TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 12     ULTRASOUND TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 13     RADIATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 14     CRYOABLATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 15     HYDROTHERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 16     NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 17     NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
      • TABLE 18     ELECTROPORATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 19     MECHANICAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 20     OTHER NON-THERMAL TECHNOLOGIES IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 21     ABLATION DEVICES GLOBAL MARKET, BY APPLICATION (2015-2023) ($MN)
      • TABLE 22     ONCOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 23     CARDIOVASCULAR APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 24     CARDIOVASCULAR APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY TYPES(2015-2023) ($MN)
      • TABLE 25     ATRIAL FIBRILATION ABLATION DEVICE GLOBAL MARKET REVENUE,BY REGION, (2015-2023) ($MN)
      • TABLE 26     ATRIAL FIBRILATION PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)
      • TABLE 27     VENTRICULAR TACHYCARDIA ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 28     VENTRICULAR TACHYCARDIA PROCEDURAL VOLUME GLOBAL MARKET,BY REGION, (2015-2023) (NO'S)
      • TABLE 29     OTHER CARDIOVASCULAR ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 30     OTHER CARDIOVASULAR PROCEDURAL VOLUME GLOBAL MARKET,BY REGION, (2015-2023) (NO'S)
      • TABLE 31     OPHTHALMOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 32     COSMETOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 33     GYNECOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET,
      • TABLE 34     GENERAL SURGERY APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION (2015-2023) ($MN)
      • TABLE 35     UROLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET,BY REGION(2015-2023) ($MN)
      • TABLE 36     ORTHOPEDIC APPLICATION OF ABLATION DEVICE GLOBAL MARKET,BY REGION(2015-2023) ($MN)
      • TABLE 37     PAIN MANAGEMENT APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION(2015-2023) ($MN)
      • TABLE 38     OTHER DISEASES APPLICATION OF ABLATION DEVICE GLOBAL MARKET,BY REGION (2015-2023) ($MN)
      • TABLE 39     ABLATION DEVICE GLOBAL MARKET REVENUE, BY END-USER, (2015-2023) ($MN)
      • TABLE 40     HOSPITALS IN ABLATION DEVICE ENDUSERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 41     AMBULATORY SURGICAL CENTRE IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 42     SPECIALITY CLINICS IN ABLATION DEVICE END USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 43     ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
      • TABLE 44     NORTH AMERICA ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 45     NORTH AMERICAN THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 46     NORTH AMERICAN NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 47     NORTH AMERICAN ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 48     NORTH AMERICAN ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
      • TABLE 49     EUROPE ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY,(2015-2023) ($MN)
      • TABLE 50     EUROPE THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 51     EUROPE NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 52     EUROPE ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 53     EUROPE ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
      • TABLE 54     ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 55     ASIA PACIFIC THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 56     ASIA PACIFIC NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 57     ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 58     ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
      • TABLE 59     ROW ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
      • TABLE 60     ROW THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE,BY TYPE (2015-2023) ($MN)
      • TABLE 61     ROW NON-THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
      • TABLE 62     ROW ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
      • TABLE 63     ROW ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
      • TABLE 64     MERGERS AND ACQUITIONS (2015-2016)
      • TABLE 65     APPROVALS (2015-2016)
      • TABLE 66     NEW PRODUCT LAUNCH (2015-2016)
      • TABLE 67     AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2015-2016)
      • TABLE 68     BUSINESS EXPANSION (2015-2016)
      • TABLE 69     ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES,(2014-2016) ($MN)
      • TABLE 70     ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 71     ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 72     ANGIODYNAMICS INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 73     ANGIODYNAMICS INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 74     ANGIODYNAMICS INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 75     ARTICURE INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 76     ARTICURE INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 77     ARTICURE INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 78     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 79     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 80     BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 81     CONMED CORPORATION: TOTAL REVENUE AND R&D EXPENSES,(2014-2016) ($MN)
      • TABLE 82     CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 83     CONMED CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 84     ELEKTA AB : TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 85     ELEKTA AB : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 86     ELEKTA AB : TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 87     HOLOGIC INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 88     HOLOGIC INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 89     HOLOGIC INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 90     JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 91     JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 92     JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 93     MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 94     MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 95     MEDTRONIC, PLC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
      • TABLE 96     MEDTRONIC, PLC: MINIMALLY INVASIVE THERAPIES REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
      • TABLE 97     MEDTRONIC, PLC: RESTORATIVE THERAPIES GROUP REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
      • TABLE 98     MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 99     OLYMPUS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
      • TABLE 100     OLYMPUS CORPORATION : TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
      • TABLE 101     OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
      • TABLE 102     SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
      • TABLE 103     SMITH & NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 104     SMITH & NEPHEW PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 105     STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES,(2014-2016) ($MN)
      • TABLE 106     STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 107     STRYKER CORPORATION: TOTAL NEUROTECHNOLOGY AND SPINE REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 108     STRYKER CORPORATION: TOTAL MEDSURG REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 109     STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
      • TABLE 110     VARIAN MEDICAL SYSTEMS: TOTAL REVENUE AND R&D EXPENSES,(2014-2016) ($MN)
      • TABLE 111     VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
      • TABLE 112     VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY,(2014-2016) ($MN)

      LIST OF FIGURES

      • FIGURE 1     ABLATION DEVICE GLOBAL MARKET SHARE, BY GEOGRAPHY (2015-2023)
      • FIGURE 2     RESEARCH METHODOLOGY: ABLATION DEVICE GLOBAL MARKET
      • FIGURE 3     ABLATION DEVICE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
      • FIGURE 4     ABLATION DEVICE GLOBAL MARKET: FORECASTING MODEL
      • FIGURE 5     ABLATION DEVICE GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
      • FIGURE 6     ABLATION DEVICES GLOBAL MARKET: MARKET SEGMENTATION
      • FIGURE 7     MARKET DYNAMICS
      • FIGURE 8     ABLATION DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2016)
      • FIGURE 9     ABLATION DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
      • FIGURE 10     ABLATION DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
      • FIGURE 11     ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016)
      • FIGURE 12     ATRIAL FIBRILLATION ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
      • FIGURE 13     RADIATION TECHNOLOGY ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016)
      • FIGURE 14     ABLATION DEVICE GLOBAL MARKET REVENUE, BY TECHNOLOGY (2015-2023) ($MN)
      • FIGURE 15     THERMAL TECHNOLOGY IN ABLATION DEVICE TECHNOLOGY GLOBAL MARKET REVENUE, BY TYPES (2016) ($MN)
      • FIGURE 16     RADIOFREQUENCY ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
      • FIGURE 17     LASER ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
      • FIGURE 18     THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, MICROWAVE APPLICATION MARKET SHARE (2016) (%)
      • FIGURE 19     ULTRASOUND ABLATION DEVICE GLOBAL MARKET SHARE,BY APPLICATION (2016) (%)
      • FIGURE 20     RADIATION ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
      • FIGURE 21     THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, CRYOABLATION APPLICATION MARKET SHARE (2016) (%)
      • FIGURE 22     NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPE (2016 V’S 2023) ($MN)
      • FIGURE 23     ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATIONS, (2016) (%)
      • FIGURE 24     CANCER ABLATION PROCEDURE VOLUME, BY DISEASE TYPES, (2016) (%)
      • FIGURE 25     ABLATION DEVICE GLOBAL MARKET REVENUE, BY END USERS (2015-2023) ($MN)
      • FIGURE 26     ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION (2015-2023) CAGR (%)
      • FIGURE 27     OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
      • FIGURE 28     OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET, BY APPLICATIONS & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 29     OUTLOOK OF U.S. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 30     OUTLOOK OF OTHER NORTH AMERICAN ABLATION DEVICE MARKET,BY APPLICATIONS, TECHNIQUES & END-USERS (2016 V’S 2023) ($MN)
      • FIGURE 31     OUTLOOK OF EUROPE ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
      • FIGURE 32     OUTLOOK OF EUROPE ABLATION DEVICE MARKET, BY APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 33     OUTLOOK OF U.K. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 34     OUTLOOK OF GERMANY ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 35     OUTLOOK OF FRANCE ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 36     OUTLOOK OF OTHER EUROPEAN ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATIONS, & END-USERS (2016 V’S 2023) ($MN)
      • FIGURE 37     OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
      • FIGURE 38     OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET, BY APPLICATION AND END USERS (2016 V’S 2023) ($MN)
      • FIGURE 39     OUTLOOK OF INDIA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 40     OUTLOOK OF CHINA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 41     OUTLOOK OF JAPAN ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 42     OUTLOOK OF OTHER ASIA PACIFIC ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATIONS & END-USERS (2016 V’S 2023) ($MN)
      • FIGURE 43     OUTLOOK OF ROW ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY (2016 V’S 2023) ($MN)
      • FIGURE 44     OUTLOOK OF ROW ABLATION DEVICE MARKET, BY APPLICATION & END-USERS (2016 V’S 2023) ($MN)
      • FIGURE 45     OUTLOOK OF MIDDLE EAST ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & ENDUSERS (2016 V’S 2023) ($MN)
      • FIGURE 46     OUTLOOK OF BRAZIL ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
      • FIGURE 47     OUTLOOK OF OTHER ROW REGION ABLATION DEVICE MARKET,BY TECHNOLOGY, APPLICATION & ENDUSER (2016 V’S 2023) ($MN)
      • FIGURE 48     KEY GROWTH STRATEGIES (2015-2016)
      • FIGURE 49     SWOT: ABBOTT LABORATORIES
      • FIGURE 50     SWOT: ANGIODYNAMICS
      • FIGURE 51     SWOT: ARTICURE INC
      • FIGURE 52     SWOT: BOSTON SCIENTIFIC CORPORATION
      • FIGURE 53     SWOT: CONMED CORPORATION
      • FIGURE 54     SWOT: ELEKTA AB
      • FIGURE 55     SWOT: HOLOGIC INC
      • FIGURE 56     SWOT: JOHNSON AND JOHNSON
      • FIGURE 57     SWOT: MEDTRONIC PLC
      • FIGURE 58     SWOT: OLYMPUS CORPORATION
      • FIGURE 59     SWOT: SMITH AND NEPHEW PLC
      • FIGURE 60     SWOT: STRYKER CORPORATION
      • FIGURE 61     SWOT: VARIAN MEDICAL SYSTEMS

      LIST OF COMPANIES MENTIONED IN THE REPORT

      • 1     ABBOTT LABORATORIES
      • 2     ACCESS POINT TECHNOLOGIES
      • 3     ACCURAY
      • 4     AISHEN MEDICAL TECHNOLOGIES
      • 5     ALCON RESEARCH
      • 6     ALMA
      • 7     ALPINION MEDICAL SYSTEMS
      • 8     ANGIODYNAMICS INC.
      • 9     APAMA MEDICAL
      • 10     APRO KOREA
      • 11     AQUILANT MEDICAL
      • 12     ARTHREX
      • 13     ARTICURE INC.
      • 14     AVINGER
      • 15     BAYLIS MEDICAL
      • 16     BEST NOMOS
      • 17     BIOLITEC AG
      • 18     BIOTRONIK
      • 19     BOSTON SCIENTIFIC CORPORATION
      • 20     BOVIE MEDICAL
      • 21     BRAINLAB INC.
      • 22     BTG PLC
      • 23     C.R. BARD
      • 24     CARDIMA INC
      • 25     CARDIOFOCUS., INC.
      • 26     CARDIOSONIC
      • 27     CARDIOVASCULAR SYSTEMS INC
      • 28     CARL ZEISS
      • 29     CATHEFFECTS LLC
      • 30     CATHETER ROBOTICS
      • 31     CHONGQIN HAIFU TECHNOLOGY CO. LTD
      • 32     CONMED CORPORATION
      • 33     CONVERGENT LASER TECHNOLOGIES
      • 34     COOLTOUCH
      • 35     COOPER SURGICAL
      • 36     CSA MEDICAL
      • 37     CURON MEDICAL, INC.
      • 38     CYNOSURE
      • 39     DIROS TECHNOLOGY
      • 40     DORNIER MEDTECH
      • 41     EDAP TMS
      • 42     ELEKTA
      • 43     EMBLATION MICROWAVE
      • 44     ENDOTHERAPEUTICS
      • 45     EV3 INC
      • 46     EYETECHCARE
      • 47     FCARE SYSTEMS
      • 48     FOCUSSTART
      • 49     FUS INSTRUMENTS
      • 50     GE MEDICAL SYSTEMS
      • 51     HANSEN MEDICAL
      • 52     HAYLARD HEALTH
      • 53     HOLOGIC
      • 54     HS MEDICAL INC.
      • 55     IMRICOR MEDICAL SYSTEMS
      • 56     INSIGHTEC
      • 57     ION BEAM APPLICATIONS SA
      • 58     JAPAN LIFELINE
      • 59     JENA SURGICAL
      • 60     JOHNSON AND JOHNSON
      • 61     KHELIX MEDICAL
      • 62     LEPU MEDICAL
      • 63     LUMENIS LTD
      • 64     MEDISPEC
      • 65     MEDLUMICS
      • 66     MEDTRONIC
      • 67     MEDWAVES
      • 68     MICROSURGEON INC.
      • 69     MINERVA SURGICAL
      • 70     MISONIX
      • 71     MONTERIS MEDICAL
      • 72     NANOSPECTRA BIOSCIENCES
      • 73     NEOLASER
      • 74     NEUSOFT MEDICAL SYSTEMS
      • 75     NIDEK CO LTD
      • 76     OLYMPUS CORPORATION
      • 77     OMEICOS THERAPEUTICS
      • 78     PANACEA MEDICAL TECHNOLOGIES
      • 79     PENTAX MEDICAL
      • 80     PERSEON CORPORATION
      • 81     PHILIPS FUS
      • 82     PROFOUND MEDICAL
      • 83     PROSTALUND AB
      • 84     PYREXAR MEDICAL
      • 85     RECOR MEDICAL
      • 86     RELIEVANT MEDSYSTEMS
      • 87     RF MEDICAL CO., LTD.
      • 88     SCHWIND EYE TECH SOLUTIONS
      • 89     SHENZEN HYDE MEDICAL EQUIPMENT
      • 90     SHINVA MEDICAL
      • 91     SMITH AND NEPHEW PLC
      • 92     SONACARE MEDICAL
      • 93     SONIC CONCEPTS INC
      • 94     SPECTRANETICS
      • 95     STEREOTAXIS
      • 96     STRYKER CORPORATION
      • 97     SYMPLE SURGICAL INC.
      • 98     TAEWOONG MEDICAL
      • 99     THERACLION
      • 100     THERALASE
      • 101     TROD MEDICAL
      • 102     UNITED MEDICAL SYSTEMS
      • 103     UROLOGIX
      • 104     VARIAN MEDICAL SYSTEMS
      • 105     VISX INC
      • 106     VIVANT MEDICAL
      • 107     WIKKON MEDICAL
      • 108     WONTECH
      • 109     ZIEMER GROUP